Search Results 2121-2130 of 18845 for Relapse
... relapse in patients with history of biochemically recurrent prostate cancer and prostate-specific antigen View PubMed; Truty MJ, Kendrick ML, Nagorney DM ...
relapse. 8. Any condition that required treatment with steroids or any other immune suppressive drugs within 14 days prior to first dose of study drug. 9 ...
This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of flare-ups (relapses) of the disease. Natalizumab ...
Quantification of clonal circulating plasma cells in relapsed multiple myeloma. Br J Haematol. 2014 Nov; 167 (4):500-5 Epub 2014 Aug 12. View PubMed ...
Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND.
Relapsed multiple myeloma presenting as nodular hepatic lesions Japanese Journal of Clinical Radiology. 2017. Hoshiai S, Sato S, Koyama K, Takahashi H ...
Subjects must be in second or later morphological complete remission (with or without platelet recovery; CR2/CRp2) for relapsed AML based on the CRp criteria as ...
... Relapse: A Cautionary Tale. J Clin Psychiatry. 2024 Aug 26; 85 (3) View PubMed; Ho MF, Zhang C, Cohan JS, Tuncturk M, Heider RM, Coombes BJ, Biernacka J ...
... relapse. Intravenous Ketamine for Treatment-Resistant Depression (G2K). Rochester, Minn. The purpose of this study is to to evaluate the relationships ...
... relapse, and subsequent therapy. Effect of Agent Orange Exposure on Endocrine Tumor Aggressiveness. Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.